Myoclonus-dystonia syndrome

Handbook of Clinical Neurology

Volumn 100, Issue , 2011, Pages 563-575

  Nardocci, Nardo ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; TOR1A PROTEIN, HUMAN;

DYSTONIC DISORDER; GENETICS; HUMAN; MUTATION; MYOCLONUS DYSTONIA; PATHOPHYSIOLOGY; REVIEW;

DYSTONIC DISORDERS; HUMANS; MOLECULAR CHAPERONES; MUTATION;

EID: 79954477841     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52014-2.00041-0     Document Type: Book

References (130)

1. Angelini L., Erba A., Mariotti C., et al. Myoclonic dystonia as unique presentation of isolated vitamin E deficiency in a young patient. Mov Disord 2002, 17:612-614.
2. 2 receptor binding in non-manifesting carriers of the DYT1 dystonia mutation. Neurology 2005, 64:347-349.
3. Asmus F., Gasser T. Inherited myoclonus-dystonia. Adv Neurol 2004, 94:113-119.
4. Asmus F., Zimprich A., Naumann M., et al. Inherited myoclonus-dystonia syndrome: narrowing the 7q21-q31 locus in German families. Ann Neurol 2001, 49:121-124.
5. Asmus F., Zimprich A., Tezenas Du Montcel S., et al. Myoclonus-dystonia syndrome: ε-sarcoglycan mutations and phenotype. Ann Neurol 2002, 52:489-492.
6. Asmus F., Hjermind L.E., Dupont E., et al. Myoclonus-dystonia due to genomic deletions in the epsilon sarcoglycan gene. Ann Neurol 2005, 58:792-797.
7. Asmus F., Hjermind L.E., Dupont E., et al. Genomic deletion size at the epsilon-sarcoglycan locus determines the clinical phenotype. Brain 2007, 130:2736-2745.
8. Asmus F., Devlin A., Munz M., et al. Clinical differentiation of genetically proven benign hereditary chorea and myoclonus-dystonia. Mov Disord 2007, 22:2104-2109.
9. Berardelli A., Rothwell J.C., Day B.L., et al. Pathophysiology of blepharospasm and oromandibular dystonia. Brain 1985, 108:593-608.
10. Berardelli A., Rothwell J.C., Hallett M., et al. The pathophysiology of primary dystonia. Brain 1998, 121:1195-1212.
11. Berardelli A., Noth J., Thompson P.D., et al. Pathophysiology of chorea and bradykinesia in Huntington's disease. Mov Disord 1999, 14:398-403.
12. Berkovic S.F., So N.K., Andermann F. Progressive myoclonus epilepsies: clinical and neurophysiological diagnosis. J Clin Neurophysiol 1991, 8:261-274.
13. Beukers R.J., Booij J., Weisscher N., et al. Reduced striatal D(2) receptor binding in myoclonus-dystonia. Eur J Nucl Med Mol Imaging 2009, 36:269-274.
14. Bonnet C., Grégoire M.J., Vibert M., et al. Cryptic 7q21 and 9p23 deletions in a patient with apparently balanced de novo reciprocal translocation t(7;9)(q21;p23) associated with a dystonia-plus syndrome: paternal deletion of the epsilon-sarcoglycan (SGCE) gene. J Hum Genet 2008, 53:876-885.
15. Borges V., Aguiar de C., Ferraz H.B., et al. Novel and de novo mutations of the SGCE gene in Brazilian patients with myoclonus-dystonia. Mov Disord 2007, 22:1208-1209.
16. Breedveld G.J., Percy A.K., MacDonald M.E., et al. Clinical and genetic heterogeneity in benign hereditary chorea. Neurology 2002, 59:579-584.
17. Breedveld G.J., van Dongen J.W., Danesino C., et al. Mutations in TITF-1 are associated with benign hereditary chorea. Hum Mol Genet 2002, 11:971-979.
18. Bressman S.B. Dystonia genotypes, phenotypes, and classification. Adv Neurol 2004, 94:101-107.
19. Bressman S.B., de Leon D., Kramer P.L., et al. Dystonia in Ashkenazy Jews: clinical characterization of a founder mutation. Ann Neurol 1994, 36:771-777.
20. Bressman S.B., Sabatti C., Raymond D., et al. The DYT1 phenotype and guidelines for diagnostic testing. Neurology 2000, 54:1746-1752.
21. Brown P., Ridding M.C., Werhahn K.J., et al. Abnormalities of the balance between inhibition and excitation in the motor cortex of patients with cortical myoclonus. Brain 1996, 119:309-317.
22. Canavese C., Ciano C., Zorzi G., et al. Polymyography in the diagnosis of childhood onset movement disorders. Eur J Paediatr Neurol 2008, 12:480-483.
23. Chan P., Gonzalez-Maeso J., Ruf F., et al. Epsilon-sarcoglycan immunoreactivity and mrna expression in mouse brain. J Comp Neurol 2005, 482:50-73.
24. Chung E.J., Lee W.Y., Kim J.Y., et al. Novel SGCE mutation in a Korean patient with myoclonus-dystonia with unique phenotype mimicking Moya-Moya disease. Mov Disord 2007, 22:1206-1207.
25. Cif L., Valente E.M., Hemm S., et al. Deep brain stimulation in myoclonus-dystonia syndrome. Mov Disord 2004, 19:724-727.
26. Coubes P., Roubertiee A., Vayessiere N., et al. Treatment of DYT1-generalised dystonia by stimulation of the globus pallidus internus. Lancet 2000, 35:2220-2221.
27. Daube J.R., Peters H.A. Hereditary essential myoclonus. Arch Neurol 1966, 15:587-594.
28. DeBerardinis R.J., Conforto D., Russell K., et al. Myoclonus in a patient with a deletion of the epsilon-sarcoglycan locus on chromosome 7q21. Am J Med Genet 2003, 121A:31-36.
29. de Vries B.B., Arts W.F., Breedveld G.J., et al. Benign hereditary chorea of early onset maps to chromosome 14q. Am J Hum Genet 2000, 66:136-142.
30. Dexter D.T., Brooks D.J., Harding A.E., et al. Nigrostriatal function in vitamin E deficiency: clinical, experimental, and positron emission tomographic studies. Ann Neurol 1994, 35:298-303.
31. Dexter D.T., Nanayakkara I., Goss-Sampson M.A., et al. Nigral dopaminergic cell loss in vitamin E deficient rats. Neuroreport 1994, 14:1773-1776.
32. do Carmo Costa M., Costa C., Silva A.P., et al. Nonsense mutation in TITF1 in a Portuguese family with benign hereditary chorea. Neurogenetics 2005, 6:209-215.
33. Doheny Do, Brin M.F., Morrison C.E., et al. Phenotypic features of myoclonus-dystonia in three kindreds. Neurology 2002, 59:1187-1196.
34. Doyle D.A., Gonzalez I., Thomas B., et al. Autosomal dominant transmission of congenital hypothyroidism, neonatal respiratory distress, and ataxia caused by a mutation of NKX2-1. J Pediatr 2004, 145:190-193.
35. Edwards M.J., Huang Y.Z., Wood N.W., et al. Different patterns of electrophysiological deficits in manifesting and non-manifesting carriers of the DYT1 gene mutation. Brain 2003, 126:2074-2080.
36. Esapa C.T., Waite A., Locke M., et al. SGCE missense mutations that cause myoclonus-dystonia syndrome impair epsilon-sarcoglycan trafficking to the plasma membrane: modulation by ubiquitination and torsina. Hum Mol Genet 2007, 16:327-342.
37. Ettinger A.J., Feng G., Sanes J.R. Epsilon-sarcoglycan, a broadly expressed homologue of the gene mutated in limb-girdle muscular dystrophy 2D. J Biol Chem 1997, 272:32534-32538.
38. Fahn S., Bressman S.B., Marsden C.D. Classification of dystonia. Adv Neurol 1998, 78:1-10.
39. Fasano A., Nardocci N., Elia A.E., et al. Non-DYT1 early-onset primary torsion dystonia: comparison with DYT1 phenotype and review of the literature. Mov Disord 2006, 21:1411-1418.
40. Foncke E.M.J., Klein M.D., Koelman J.H.T.M., et al. Hereditary myoclonus-dystonia associated with epilepsy. Neurology 2003, 60:1988-1990.
41. Frucht S. The clinical spectrum of posthypoxic myoclonus. Mov Disord 2000, 15:2-7.
42. Frucht S.J., Bordelon Y., Houghton W.H. Marked amelioration of alcohol-responsive posthypoxic myoclonus by gamma-hydroxybutyric acid (Xyrem). Mov Disord 2005, 20:745-751.
43. Gasser T. Inherited myoclonus-dystonia. Adv Neurol 1998, 78:325-334.
44. Gerrits M.C., Foncke E.M., de Haan R., et al. Phenotype-genotype correlation in Dutch patients with myoclonus-dystonia. Neurology 2006, 66:759-761.
45. Gilio F., Currà A., Lorenzano C., et al. Effects of botulinum toxin type A on intracortical inhibition in patients with dystonia. Ann Neurol 2000, 48:20-26.
46. Goetz C.G., Horn S.S. Treatment of tremor and dystonia. Neurol Clin 2001, 9:129-144.
47. Grabowski M., Zimprich A., Lorenz-Depiereux B., et al. The epsilon sarcoglycan (SGCE) mutated in myoclonus-dystonia syndrome is maternally imprinted. Eur J Hum Genet 2002, 11:138-144.
48. Grimes D.A., Han F., Lang A.E., et al. A novel locus for inherited myoclonus-dystonia on 18p11. Neurology 2002, 59:1183-1186.
49. Grünewald A., Djarmati A., Lohmann-Hedrich K., et al. Myoclonus-dystonia: significance of large SGCE deletions. Hum Mutat 2008, 29:331-332.
50. Guettard E., Portinoi M.F., Lohmann-Hedrich K., et al. Myoclonus-dystonia due to maternal uniparental disomy. Arch Neurol 2008, 65:1380-1385.
51. Han F., Lang A.E., Racacho L., et al. Mutations in the ε-sarcoglycan gene found to be uncommon in seven myoclonus-dystonia families. Neurology 2003, 61:244-246.
52. Han F., Racacho L., Lang A.E., et al. Refinement of the DYT15 locus in myoclonus-dystonia. Mov Disord 2007, 22:888-892.
53. Han F., Racacho L., Yang H., et al. Large deletions account for an increasing number of mutations in the SGCE. Mov Disord 2008, 23:456-460.
54. Hanajima R., Ugawa Y., Terao Y., et al. Ipsilateral cortico-cortical inhibition of the motor cortex in various neurological disorders. J Neurol Sci 1996, 140:109-116.
55. Hedrich K., Meyer E.M., Schüle B., et al. Myoclonus-dystonia: detection of novel, recurrent and de novo SGCE mutations. Neurology 2004, 62:1229-1231.
56. Hess C.W., Raymond D., de Carvalho-Aguiar P., et al. Myoclonus-dystonia, obsessive-compulsive disorder, and alcohol dependence in SGCE mutation carriers. Neurology 2007, 68:522-524.
57. Ichinose H., Ohye T., Takahiashi E., et al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase gene. Nat Gen 1994, 8:236-242.
58. Jankovic J. Treatment of dystonia. Lancet Neurol 2006, 5:864-872.
59. Klein C. Myoclonus and myoclonus-dystonias. Genetics of Movement Disorders 2002, 449-469. Academic Press, San Diego. S. Pulst (Ed.).
60. Klein C., Brin M.F., Kramer P., et al. Association of a missense change in the D2 dopamine receptor with myoclonus-dystonia. Proc Natl Acad Sci U S A 1999, 96:5173-5176.
61. Klein C., Schilling K., Saunders-Pullman R.J., et al. A major locus for myoclonus-dystonia maps to chromosome 7q in eight families. Am J Hum Genet 2000, 67:1314-1319.
62. Klein C., Liu L., Doheny D., et al. Epsilon-sarcoglycan mutations found in combination with other dystonia gene mutations. Ann Neurol 2002, 52:675-679.
63. Kleiner-Fisman G., Lang A.E. Benign hereditary chorea revisited: a journey to understanding. Mov Disord 2007, 16:2297-2305.
64. Kleiner-Fisman G., Rogaeva E., Halliday W., et al. Benign hereditary chorea: clinical, genetic, and pathological findings. Ann Neurol 2003, 54:244-247.
65. Koukouni V., Valente E.M., Cordivari C., et al. Unusual familial presentation of epsilon-sarcoglycan gene mutation with falls and writer's cramp. Mov Disord 2008, 23:1913-1914.
66. Kralic J.E., Criswell H.E., Osterman J.L., et al. Genetic essential tremor in gamma-aminobutyric acid receptor alpha1 subunit knockout mice. J Clin Invest 2005, 115:774-779.
67. Krude H., Schutz B., Biebermann H., et al. Choreoathetosis, hypothyroidism, and pulmonary alterations due to human NKX2-1 haploinsufficiency. J Clin Invest 2002, 109:475-480.
68. Kyllerman M., Forsgren L., Sanner G., et al. Alcohol-responsive myoclonic dystonia in a large family: dominant inheritance and phenotypic variation. Mov Disord 1990, 5:270-279.
69. Lehesjoki A.E. Clinical features and genetics of Unverricht-Lundborg disease. Adv Neurol 2002, 89:193-197.
70. Lehesjoki A.E., Koskiniemi M., Sistonen P., et al. Localization of a gene for progressive myoclonus epilepsy to chromosome 21q22. Proc Natl Acad Sci U S A 1991, 88:3696-3699.
71. Leli D.A., Furlow T.W., Falgout J.C. Benign familial chorea: an association with intellectual impairment. J Neurol Neurosurg Psychiatry 1984, 47:471-474.
72. Leuzzi V., Ca Carducci, Cl Carducci, et al. Autosomal dominant GTP-CH deficiency presenting as a dopa-responsive myoclonus-dystonia syndrome. Neurology 2002, 59:1241-1243.
73. Li J.Y., Cunic D.I., Paradiso G., et al. Electrophysiological features of myoclonus-dystonia. Mov Disord 2008, 23:2055-2061.
74. Lindenmuldre F.G. Familial myoclonia occurring in three successive generations. J Nerv Ment Dis 1933, 77:489-492.
75. Liu X., Griffin I.C., Parkin S.G., et al. Involvement of the medial pallidum in focal myoclonic dystonia: a clinical and neurophysiological case study. Mov Disord 2002, 17:346-353.
76. Magarinos-Ascone C.M., Regidor I., Martinez-Castrillo J.C., et al. Pallidal stimulation relieves myoclonus-dystonia syndrome. J Neurol Neurosurg Psychiatry 2005, 76:989-991.
77. Mahloudji M., Pickienly R.T. Hereditary essential myoclonus. Brain 1967, 90:669-674.
78. Manganotti P., Tamburin S., Zanette G., et al. Hyperexcitable cortical responses in progressive myoclonic epilepsy: a TMS study. Neurology 2001, 57:1793-1799.
79. Maréchal L., Raux G., Dumanchin C., et al. Severe myoclonus-dystonia syndrome associated with a novel epsilon-sarcoglycan gene truncating mutation. Am J Med Genet 2003, 119:114-117.
80. Marelli C., Canafoglia L., Zibordi F., et al. A neurophysiological study of myoclonus in patients with DYT11 myoclonus-dystonia syndrome. Mov Disord 2008, 23:2041-2048.
81. Marsden C.D., Hallett M., Fahn S. The nosology and pathophysiology of myoclonus. Movement Disorders 1982, 196-248. Butterworths, London. C.D. Marsden, S. Fahn (Eds.).
82. Mascalchi M., Michelucci R., Cosottini M., et al. Brainstem involvement in Unverricht-Lundborg disease (EPM1): an MRI and 1H MRS study. Neurology 2002, 58:1686-1689.
83. McNally E.M., Ly C.T., Kunkel L.M. Human epsilon-sarcoglycan is highly related to alpha-sarcoglycan (adhalin), the limb girdle muscular dystrophy 2D gene. FEBS Lett 1998, 422:27-32.
84. Meunier S., Lourenco G., Roze E., et al. Cortical excitability in DYT11 positive myoclonus-dystonia. Mov Disord 2008, 23:761-764.
85. Mihic S.J., Ye Q., Wick M.J., et al. Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors. Nature 1997, 389:385-389.
86. Mir P., Huang Y.Z., Gilio F., et al. Abnormal cortical and spinal inhibition in paroxysmal kinesigenic dyskinesia. Brain 2005, 128:291-299.
87. Misbahuddin A., Placzek M., Lennox G., et al. Myoclonus-dystonia syndrome with severe depression is caused by an exon skipping mutation in the ε-sarcoglycan gene. Mov Disord 2007, 22:1173-1175.
88. Müller B., Hedrich K., Kock N., et al. Evidence that paternal expression of the epsilon-sarcoglycan gene accounts for reduced penetrance in myoclonus-dystonia. Am J Hum Genet 2002, 71:1303-1311.
89. Nakashima K., Thompson P.D., Rothwell J.C., et al. An exteroceptive reflex in the sternocleidomastoid muscle produced by electrical stimulation of the supraorbital nerve in normal subjects and patients with spasmodic torticollis. Neurology 1989, 39:1354-1358.
90. Nardocci N., Zorzi G., Barzaghi C., et al. Myoclonus-dystonia syndrome: clinical presentation, disease course, and genetic features in 11 families. Mov Disord 2008, 23:28-34.
91. 123I]β-CIT. Mov Disord 1998, 13:319-323.
92. Nishiyama A., Endo T., Takeda S., et al. Identification and characterization of epsilon-sarcoglycans in the central nervous system. Brain Res Mol Brain Res 2004, 125:1-12.
93. Nygaard T.G., Raymond D., Chen C., et al. Localization of a gene for myoclonus-dystonia to chromosome 7q21-q31. Ann Neurol 1999, 46:794-798.
94. Obeso J.A., Rothwell J.C., Lang A.E., et al. Myoclonic dystonia. Neurology 1983, 33:825-830.
95. O'Riordan S., Ozelius L.J., de Carvalho Aguiar P., et al. Inherited myoclonus-dystonia and epilepsy; further evidence of an association?. Mov Disord 2004, 19:1456-1459.
96. Orth M., Djarmati A., Bäumer T., et al. Autosomal dominant myoclonus-dystonia and Tourette syndrome in a family without linkage to the SGCE gene. Mov Disord 2007, 22:2090-2096.
97. Ostrem J.L., Starr P. Treatment of dystonia with deep brain stimulation. Neurotherepaeutics 2008, 5:320-330.
98. Ozelius L.J., Hewett J.W., Page C.E., et al. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat. Genet 1997, 17:40-48.
99. Priori A., Bertolasi L., Pesenti A., et al. Gamma-hydroxybutyric acid for alcohol sensitive myoclonus with dystonia. Neurology 2000, 54:1706.
100. Quinn N.P. Essential myoclonus and myoclonic dystonia. Mov Disord 1996, 11:119-124.
101. Quinn N.P., Marsden C.D. Dominant inherited myoclonic dystonia with dramatic response to alcohol. Neurology 1984, 34:236-237.
102. Quinn N.P., Rothwell J.C., Thomson P.D., et al. Hereditary myoclonic dystonia, hereditary torsion dystonia and hereditary essential myoclonus: an area of confusion. Adv Neurol 1988, 50:391-401.
103. Raymond D., Saunders-Pullman R., de Carvalho Aguiar P., et al. Phenotypic spectrum and sex effects in eleven myoclonus-dystonia families with epsilon-sarcoglycan mutations. Mov Disord 2008, 23:88-592.
104. Rayner R.J., Doran R., Roussounis S.H. Isolated vitamin E deficiency and progressive ataxia. Arch Dis Child 1993, 69:602-603.
105. Ridding M.C., Sheean G., Rothwell J.C., et al. Changes in the balance between motor cortical excitation and inhibition in focal, task specific dystonia. J Neurol Neurosurg Psychiatry 1995, 59:493-498.
106. Ritz K., Gerrits M.C.F., Fonke E.M.J., et al. Myoclonus-dystonia: clinical and genetic evaluation of a large cohort. J Neurol Neurosurg Psychiatry 2009, 80:653-658.
107. Roze E., Apartis E., Clot F., et al. Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations. Neurology 2008, 70:1010-1016.
108. Sanghera M., Grossman R.G., Kalhorn C.G., et al. Basal ganglia neuronal discharge in primary and secondary dystonia in patients undergoing pallidotomy. Neurosurgery 2003, 352:1358-1373.
109. Saunders-Pullman R., Shriberg J., Heiman G., et al. Myoclonus-dystonia: possible association with obsessive-compulsive disorder and alcohol dependence. Neurology 2002, 58:242-245.
110. Scheidtmann K., Muller F., Hartmann E., et al. Familial myoclonus-dystonia syndrome associated with panic attacks. Nervenarzt 2000, 71:839-842.
111. Schrag A., Quinn N.P., Bhatia K.P., et al. Benign hereditary chorea- entity or syndrome?. Mov Disord 2000, 15:280-288.
112. Schüle B., Kock N., Svetel M., et al. Genetic heterogeneity in ten families with myoclonus-dystonia. J Neurol Neurosurg Psychiatry 2004, 75:1181-1185.
113. Shibasaki H. Electrophysiological studies of myoclonus. Muscle Nerve 2000, 23:321-335.
114. Swoboda K.J., Hyland K. Diagnosis and treatment of neurotransmitter-related disorders. Neurol Clin North Am 2002, 20:1143-1161.
115. Tarsky D., Simon D.K. Dystonia. N Engl J Med 2006, 335:818-829.
116. Tezenas du Montcel S., Clot F., Vidailhet M., et al. Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromes. J Med Genet 2006, 43:394-400.
117. Thobois S., Gervais-Bernard H., Xie-Brustolin J., et al. Evidence of progressive changes in clinical presentation of myoclonus-dystonia. Mov Disord 2007, 22:1516-1517.
118. Trottenberg T., Meissner W., Kabus C., et al. Neurostimulation of the ventral intermediate thalamic nucleus in inherited myoclonus-dystonia syndrome. Mov Disord 2001, 16:769-771.
119. Tunnicliff G. Sites of action of gamma-hydroxybutyrate (GHB), a neuroactive drug with abuse potential. J Toxicol Clin Toxicol 1997, 35:581-590.
120. Valente E.M., Warner T.T., Jarman P.R., et al. The role of DYT1 in primary torsion dystonia in Europe. Brain 1998, 121:2235-2239.
121. Valente E.M., Misbahuddin A., Brancati F., et al. Analysis of the e{open}-sarcoglycan gene in familial and sporadic myoclonus-dystonia: evidence for genetic heterogeneity. Mov Disord 2003, 18:1047-1051.
122. Valente E.M., Edwards M.J., Mir P., et al. The e{open}-sarcoglycan gene in myoclonic syndromes. Neurology 2005, 64:737-739.
123. Vidailhet M., Tassin J., Durif F., et al. A major locus for several phenotypes of myoclonus - dystonia on chromosome 7q. Neurology 2001, 56:1213-1216.
124. Willemsen M.A., Breedveld G.J., Wouda S., et al. Brain-thyroid-lung syndrome: a patient with a severe multi-system disorder due to a de novo mutation in the thyroid transcription factor 1 gene. Eur J Pediatr 2005, 164:28-30.
125. Wu Y., Saima A., Gholamreza A., et al. GHB and GABA-b receptor binding sites are distinctive from one another: molecular evidence. Neuropharmacology 2004, 47:1146-1156.
126. Xiao J., Le Doux M.S. Cloning, developmental regulation and neural localization of rat epsilon-sarcoglycan. Brain Res Mol Brain Res 2003, 119:132-143.
127. Yokota T., Uchihara T., Kumagai J., et al. Postmortem study of ataxia with retinitis pigmentosa by mutation of the α-tocopherol transfer protein gene. J Neurol Neurosurg Psychiatry 2000, 68:521-525.
128. Zimprich A., Grabowski M., Asmus F., et al. Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet 2001, 29:66-69.
129. Zorzi G., Garavaglia B., Invernizzi F., et al. Frequency of DYT1 mutation in early onset primary dystonia in Italian patients. Mov Disord 2002, 17:407-408.
130. Zorzi G., Marras C., Nardocci N., et al. Stimulation of the globus pallidus internus for childhood onset dystonia. Mov Disord 2005, 20:1194-1200.